专利号:US-9273023-B2 优先权日:2011-11-01 标 题:Modular synthesis of graphene nanoribbons and graphene substructures from oligo-alkynes 发明人:ALABUGIN IGOR; BYERS PHILIP M 权利人:UNIV FLORIDA STATE RES FOUND 摘要:A method for the synthesis of carbon-based structures, particularly graphene substructures and ribbons, from oligo- and poly-alkyne starting materials.
专利号:US-5859233-A 优先权日:1996-02-21 标 题 :Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates 发明人:HIRSCHBEIN BERNARD L; FEARON KAREN L; GRYAZNOV SERGEI M; MCCURDY SARAH N; NELSON JEFFREY S; SCHULTZ RONALD G 权利人:LYNX THERAPEUTICS INC 摘要:The invention provides a method of synthesizing oligonucleotide N3'->P5' phosphoramidates using an amine-exchange reaction of phosphoramidites in which a -deprotected 3'-amino group of a solid phase supported oligonucleotide chain is exhanged for the amino portion of a 5'-phosphoramidite of an incoming monomer which has a protected 3'-amino group. The resulting internucleotide phosphoramidite linkage is then oxidized to form a stable protected phosphoramidate linkage. The method of the invention greatly improves product yields and reduces reagent usage over currently available methods for synthesizing the above class of compound.
专利号:US-12168720-B2 优先权日:2019-02-19 标 题:Synthesis of functionalized polymers through devulcanization from waste containing elastomers 发明人:DEZ ISABELLE; GAUMONT ANNIE-CLAUDE; NOËL JEAN-NICOLAS 权利人:CENTRE NAT RECH SCIENT; UNIV CAEN; ECOLE NAT SUPERIEURE DINGENIEURS DE CAEN 摘要:A method for synthesising polymers through devulcanisation from waste containing elastomers, the method including:a) contacting the waste containing elastomers with a solvent in the presence of a devulcanisation agent,b) heating the mixture produced in step a), at a temperature of between 20° C. and 250° C. for a period of between 15 minutes and 24 hours in the presence of a devulcanisation agent, the concentration of devulcanisation agent, and the ratio between the concentration of devulcanisation agent, expressed as parts per hundred of elastomer (phr) and a volume of solvent, expressed in ml, is:greater than 0.3 phr/ml of solvent or less than 0.2 phr/ml of solvent when the method is carried out in air,greater than 0.06 phr/ml of solvent when the method is carried out in an inert atmosphere.
专利号:US-5824793-A 优先权日:1996-02-21 标题:Solid phase synthesis of oligonucleotide N3'-P5' phosphoramidates 发明人:HIRSCHBEIN BERNARD L; FEARON KAREN L; GRYAZNOV SERGEI M; MCCURDY SARAH N; NELSON JEFFERY S; SCHULTZ RONALD G 权利人:LYNX THERAPEUTICS INC 摘要:The invention provides a method of synthesizing oligonucleotide N3'->P5' phosphoramidates using an amine-exchange reaction of phosphoramidites in which a deprotected 3'-amino group of a solid phase supported oligonucleotide chain is exhanged for the amino portion of a 5'-phosphoramidite of an incoming monomer which has a protected 3'-amino group. The resulting internucleotide phosphoramidite linkage is then oxidized to form a stable protected phosphoramidate linkage. The method of the invention greatly improves product yields and reduces reagent usage over currently available methods for synthesizing the above class of compound.
专利号:US-2023135188-A1 优先权日:2017-07-06 标题:Fe/cu-mediated ketone synthesis 发明人:KISHI YOSHITO; YAHATA KENZO; KUMAR VEMULA PRAVEEN; VADDELA SUDHEER BABU 权利人:HARVARD COLLEGE 摘要:Provided herein are methods for preparing ketone-containing organic molecules. The methods are based on novel iron/copper-mediated (“Fe/Cu-mediatedâ€?) coupling reactions. The Fe/Cu-mediated coupling reaction can be used in the preparation of complex molecules, such as halichondrins and analogs thereof. In particular, the Fe/Cu-mediated ketolization reactions described herein are useful in the preparation of intermediates en route to halichondrins.
专利号:US-2018111958-A1 优先权日:2008-12-02 标 题 :Method for the synthesis of phosphorus atom modified nucleic acids
1: Haber SL, Benson V, Buckway CJ, Gonzales JM, Romanet D, Scholes B. Lifitegrast: a novel drug for patients with dry eye disease. Ther Adv Ophthalmol. 2019 Aug 22;11:2515841419870366. doi: 10.1177/2515841419870366. eCollection 2019 Jan-Dec. Review. 2: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500874/ doi: 10.2147/OPTH.S126668. eCollection 2018. Review. 4: Donnenfeld ED, Perry HD, Nattis AS, Rosenberg ED. Lifitegrast for the treatment of dry eye disease in adults. Expert Opin Pharmacother. 2017 Oct;18(14):1517-1524. doi: 10.1080/14656566.2017.1372748. Epub 2017 Sep 4. Review. doi: 10.2147/OPTH.S117188. eCollection 2017. Review.
合成参考文献
参考文献:10.1089/jop.2012.0210 摘要:Yandrapu S, Kompella UB. Development of Sustained-Release Microspheres for the Delivery of SAR 1118, an LFA-1 Antagonist Intended for the Treatment of Vascular Complications of the Eye. Journal of Ocular Pharmacology and Therapeutics. 2013 Mar;29(2):236–48. doi: 10.1089/jop.2012.0210. 参考文献:10.2174/138161206777947731 摘要:Giblin PA, Lemieux RM. LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics. Curr Pharm Des. 2006;12(22):2771–95. doi: 10.2174/138161206777947731.